Evidence map›Paper›PMID 23157335›Full record

ReviewAnnual review of pathology2013

The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin.

Casey T Weaver, Charles O Elson, Lynette A Fouser, Jay K Kolls

Abstract readReview
In one paragraph

Review in Annual review of pathology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 265 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
265citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

265 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Review
  8. Ryanodine Receptor 1 Is Dispensable for CD4European journal of immunology · 2026
    Article
  9. Journal of thoracic disease · 2026
    Article
  10. Observational
  11. Dissecting PGENature communications · 2026
    Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

205 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Casey T WeaverDepartment of Pathology, University of Alabama at Birmingham,AL 35294, USA. cweaver@uab.edu
Charles O Elson
Lynette A Fouser
Jay K Kolls

Funding

INNATE AND ADAPTIVE MICROBIAL IMMUNITY IN IBDP01DK071176 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ELSON, CHARLES O · 2005 to 2014
$12.5M
Mucosal HIV and Immunobiology CenterR24DK064400 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SMITH, PHILLIP D · 2003 to 2012
$4.8M
Th17 Cytokines and Lung ImmunityR37HL079142 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KOLLS, JAY K · 2010 to 2017
$3.6M
NON CD4 HOST DEFENSE AGAINST P CARINII PNEUMONIAR01HL061271 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KOLLS, JAY K · 1999 to 2013
$3.6M
POSTTHYMIC T-CELL FUNCTIONAL REPERTOIRE HETEROGENEITYR01AI035783 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WEAVER, CASEY T · 1994 to 2010
$2.4M
Immune Regulation to Intestinal Bacterial AntigensR01AI057956 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WEAVER, CASEY T · 2004 to 2008
$1.8M
Factors Controlling Effector T Cell Maintenance in the Pathogenesis of ColitisR01DK093015 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WEAVER, CASEY T · 2011 to 2015
$1.6M
Control of chromatin landscapes in effector T cell lineage specificationsR01AI077574 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WEAVER, CASEY T · 2009 to 2012
$1.5M
NHLBI NIH HHS R01 HL061271NHLBI NIH HHS R37 HL079142NIAID NIH HHS R01 AI035783NIAID NIH HHS R01 AI057956NIAID NIH HHS R01 AI077574NIDDK NIH HHS P01 DK071176NIDDK NIH HHS R01 DK093015NIDDK NIH HHS R24 DK064400
6 · The paper itself

Abstract

The recent discovery of a new CD4+ T cell subset, Th17, has transformed our understanding of the pathogenetic basis of an increasing number of chronic immune-mediated diseases. Particularly in tissues that interface with the microbial environment-such as the intestinal and respiratory tracts and the skin-where most of the Th17 cells in the body reside, dysregulated immunity to self (or the extended self, the diverse microbiota that normally colonize these tissues) can result in chronic inflammatory disease. In this review, we focus on recent advances in the biology of the Th17 pathway and on genome-wide association studies that implicate this immune pathway in human disease involving these tissues.

Indexed as

AnimalsColitisDermatitisHumansImmunologic FactorsPneumoniaTh17 CellsImmunologic Factors

Identifiers

PMID23157335
PMCPMC3965671

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.